Summary
Bio Techne Corp (Bio Techne), formerly Techne Corporation is a life science company that develops, produces and sells biotechnology products and hematology products. The company develops and manufactures hematology controls used in hospitals and clinical laboratories to check the accuracy of blood analysis instruments. It also develops and manufactures biotechnological products such as purified proteins, assays, enzymes, diagnostic kits and antibodies. Bio Techne’s products find application in scientific investigations into biological processes and to find out the nature and progress of particular diseases. The company markets its products through its distribution centers across the world. It offers its products to research and clinical diagnostic communities. Bio Techne is headquartered in Minneapolis, Minnesota, the US.
Bio Techne Corp (TECH) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Bio Techne Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Bio Techne Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Bio Techne Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Bio Techne Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Bio Techne Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Bio Techne Corp, Medical Equipment, Deal Details 12
Venture Financing 12
Advanced Cell Diagnostics Raises USD22 Million in Series C Financing 12
CyVek Raises US$2 Million Venture Financing Round 13
CyVek Raises US$5.5 Million In Series D Financing 13
Advanced Cell Diagnostics Raises US$12 Million In Series B Financing 14
Cell Biosciences Secures US$13 Million In Second Tranche Of Series F Financing 15
Partnerships 17
Bio-Techne Enters into Agreement with B-MoGen Biotechnologies 17
Leica Biosystems Enters into Agreement with Advanced Cell Diagnostics 17
Luminex Enters into Distribution Agreement with Bio-Techne 18
Indica Labs Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 19
MicroMatrices Associates Enters into Co-Development Agreement with Advanced Cell Diagnostics 19
Leica Biosystems Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 20
TGA Sciences Partners with CyVek 21
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 21
Advanced Cell Diagnostics Enters Into Co-Development Agreement With Definiens 22
Equity Offering 23
Astute Medical Raises USD43 Million in Private Palcement of Shares 23
ProteinSimple Withdraws IPO 24
Acquisition 25
Bio-Techne Acquires Advanced Cell Diagnostics 25
Bio-Techne to Acquire Cliniqa 26
Bio-Techne Acquires Remaining Stake in Cyvek 27
Bio-Techne Completes Acquisition of ProteinSimple for USD308 Million 28
Techne Completes Acquisition Of Bionostics For US$104 Million 29
Cell Biosciences Acquires Brightwell Technologies 31
Techne Acquires Boston Biochem And Boston Biochem 31
Bio Techne Corp - Key Competitors 33
Key Employees 34
Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 37
Financial Announcements 37
Feb 07, 2017: Bio-Techne Releases Second Quarter Fiscal 2017 Results 37
Oct 31, 2016: Bio-Techne Releases First Quarter Fiscal 2017 Results 39
Aug 17, 2016: Bio-Techne Releases Fourth Quarter Fiscal 2016 Results 41
May 03, 2016: Bio-Techne Releases Third Quarter Fiscal 2016 Results 44
Feb 02, 2016: Bio-Techne Releases Second Quarter Fiscal 2016 Results 46
Other Significant Developments 48
Jan 09, 2017: COPD Biomarker Qualification Consortium Partners with Bio-Techne to Identify COPD Indicator 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49
List of Tables
Bio Techne Corp, Medical Equipment, Key Facts, 2016 1
Bio Techne Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Bio Techne Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Bio Techne Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Bio Techne Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Bio Techne Corp, Deals By Market, 2011 to YTD 2017 9
Bio Techne Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Advanced Cell Diagnostics Raises USD22 Million in Series C Financing 12
CyVek Raises US$2 Million Venture Financing Round 13
CyVek Raises US$5.5 Million In Series D Financing 13
Advanced Cell Diagnostics Raises US$12 Million In Series B Financing 14
Cell Biosciences Secures US$13 Million In Second Tranche Of Series F Financing 15
Bio-Techne Enters into Agreement with B-MoGen Biotechnologies 17
Leica Biosystems Enters into Agreement with Advanced Cell Diagnostics 17
Luminex Enters into Distribution Agreement with Bio-Techne 18
Indica Labs Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 19
MicroMatrices Associates Enters into Co-Development Agreement with Advanced Cell Diagnostics 19
Leica Biosystems Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 20
TGA Sciences Partners with CyVek 21
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 21
Advanced Cell Diagnostics Enters Into Co-Development Agreement With Definiens 22
Astute Medical Raises USD43 Million in Private Palcement of Shares 23
ProteinSimple Withdraws IPO 24
Bio-Techne Acquires Advanced Cell Diagnostics 25
Bio-Techne to Acquire Cliniqa 26
Bio-Techne Acquires Remaining Stake in Cyvek 27
Bio-Techne Completes Acquisition of ProteinSimple for USD308 Million 28
Techne Completes Acquisition Of Bionostics For US$104 Million 29
Cell Biosciences Acquires Brightwell Technologies 31
Techne Acquires Boston Biochem And Boston Biochem 31
Bio Techne Corp, Key Competitors 33
Bio Techne Corp, Key Employees 34
Bio Techne Corp, Subsidiaries 35
List of Figures
Bio Techne Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Bio Techne Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Bio Techne Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Bio Techne Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Bio Techne Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Bio Techne Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
Bio Techne Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Bio Techne Corp, Medical Equipment, Deals by Market, 2011 to YTD 2017 9
